SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Thursday reported a loss of $91.4 million in its first quarter.

On a per-share basis, the Salt Lake City-based company said it had a loss of 39 cents.

The biotechnology company posted revenue of $13.8 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $13.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RXRX at https://www.zacks.com/ap/RXRX